Author: VOLITION DIAGNOSTICS UK LIMITED

Posted Date:

January 30, 2026

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

VOLITION DIAGNOSTICS UK LIMITED

January 30, 2026
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

VOLITION DIAGNOSTICS UK LIMITED

January 28, 2026